Accutane linked to severe skin reactions
-CBC News
02/17/2010 - Rare but potentially deadly skin reactions have been found in people using Accutane to treat severe acne, Health Canada says. The department, in consultation with the drug's manufacturer, Hoffmann-La Roche, released the public advisory on Tuesday. "There have been very rare post-marketing reports of severe skin reactions," Health Canada said in a letter to health-care professionals. "These events may be serious in nature and can result in hospitalization, disability or death," it added in its advisory to the public. More>>>

Roche Ordered to Pay $25 Million to Accutane User
-Bloomberg
02/16/2010 - Roche Holding AG, the Swiss drugmaker, must pay $25.16 million in damages to a former user of its Accutane drug who blamed the acne medicine for his inflammatory bowel disease, a New Jersey jury ruled. Andrew McCarrell, 38, won the verdict today at a retrial in Atlantic City, New Jersey. An appeals court ordered the new trial after overturning a $2.62 million award he won in May 2007. McCarrell, a computer technician from Birmingham, Alabama, testified he got sick after taking the drug for acne in 1995. He needed five surgeries, including one to remove his colon. More>>>

Teen Says Acne Medication Accutane Caused Disease
-WFTV News
02/15/2010 - The family of an Apopka boy is in the process of filing suit against the maker of the prescription drug, Accutane. It's a medication that treats severe acne. Accutane has been involved in hundreds of lawsuits because of its sometimes deadly side effects. One 17-year-old boy says the drug made him so sick for so long that he can't attend school. More>>>

N.J. Court Revives Accutane Suicide Suit, Reversing Exclusion of Expert Opinion
-The National Law Journal
02/05/2010 - A New Jersey suit alleging Accutane caused a 19-year-old's suicide is back on track, thanks to an appeals court ruling that gives the plaintiffs another shot at admitting expert testimony that the acne drug causes depression. More>>>

Acne Meds Accutane & Claravis Took Her Colon, Woman Says
-Courthouse News
01/11/2010 - A woman says Roche Laboratories' acne drug Accutane and its generic form Claravis gave her such a bad case of inflammatory bowel disease she had to have her colon removed. Roche pulled the drug from the market in June 2009, but it was too late for her, Nazeena Gangji claims in Essex County Court. More>>>

Ranbaxy recalls drugs for skin disease from US
-IndianExpress
11/23/2009 - Ranbaxy Laboratories has recalled from the US market a batch of 4,348 cartons of Sotret Isotretinoin capsules used in treating skin infections. According to the information available on US health regulator Food and Drug Administration's (FDA) website, Ranbaxy through its US-based subsidiary Ranbaxy Laboratories Inc, has issued a 'nation-wide class III recall' for a batch of Sotret Isotretinoin capsules of 40 mg strength. More>>>

Quebec's pregnant women taking dangerous drugs
-The Gazette
11/18/2009 - Physicians have long known that anti-acne drug Accutane increases by 10 times the risk of a congenital malformation if taken by pregnant women. At least six per cent of pregnant women in Quebec take prescription medications that are known to harm the fetus, raising questions about the medical judgment of some of their physicians, especially general practitioners, suggests a new study by Université de Montréal researchers. More>>>

Daily Dose: The Mysterious Disappearing Accutane
-Woman’s Day
11/14/2009 - Ever since my early 20s I’ve been fortunate to have decent skin (I consider it payback for having pretty bad breakouts during my teen years), but I’ve known several people for whom topical creams just weren’t enough to combat blemishes. That’s when they turned to Accutane (isotretinoin), an oral medication that works wonders for the skin but is known for major side effects, including serious birth defects. More>>>

Roche stops market Accutane over IBD link
-The Examiner
11/11/2009 - Accutane a sobriquet of the formal isotretinoin, a type of vitamin A, that has been manufactured since 1982. During its registered patent that ended in 2002, was linked to serious birth defects. Women who took it had to sign a consent form, prescribed two forms of oral contraceptives, submit to monthly pregnancy tests, and register with the government. More>>>

New Studay May Deal Final Blow To Acne Drug Accutane
-LA Times
11/07/2009 - Swiss-based Roche Holding quietly pulled its blockbuster drug Accutane off the market in June amid early signs that the drug may be linked to inflammatory bowel disease. And last week, a study was released that quantified those risks, finding that users of the medication have almost twice the odds of developing a serious bowel disorder as nonusers. More>>>

Hylla to hear motions in Accutane suit
-The St.Clair Record
11/01/2009 - It's been over a month since Madison County Circuit Judge David Hylla heard arguments in a case over the acne drug Accutane and, with the case's Oct. 19 trial date past, he is scheduled to hear more motions in the suit on Nov. 3. More>>>

Isotretinoin Use Linked to Increased Risk of IBD: Presented at ACG
-DoctorsGuide
11/01/2009 - Results from a retrospective study presented here at the American College of Gastroenterology (ACG) 74th Annual Scientific Meeting suggest that use of isotretinoin is associated with the development of inflammatory bowel disease (IBD). More>>>

Ennis & Ennis, P.A. is Still Accepting Accutane Cases against Hoffman La-Roche
-OpenPress
10/27/2009 - Ennis & Ennis, P.A. announces today it is still investigating and accepting Accutane cases against the manufacturer of the drug Hoffman La-Roche. David Ennis states, "although Hoffman La-Roche announced in June 2009 that it will no longer sell Accutane due to generic competition and large legal costs defending the drug this does not absolve La-Roche from liability from patients who took the drug in the past and have suffered Inflammatory Bowel Disease (IBD), Ulcerative Colitis and Crohn’s Disease". More>>>

Accutane trial continues with discovery, trial had been set for Oct. 19
- Madison County Record
10/21/2009 - What would have been Madison County's first trial involving acne medicine Accutane has been put off again as discovery in the case continues. Plaintiff Jason Peipert filed notice of another deposition Oct. 13 as the defendants in the case have attempted to bar an unpublished study by the University of North Carolina. More>>>

Hylla hears motions in Accutane case set for trial Oct. 19
-The Madison County Record
09/25/2009 - A defense motion to bar a doctor's testimony regarding whether he warned patients about the risks of taking acne medicine Accutane was granted Thursday by Madison County Circuit Judge David Hylla. More>>>

Hylla to hear motions Thursday in Accutane case
-The Madison Record
09/24/2009 -Madison County Circuit Judge David Hylla is scheduled to hear motions Thursday in a medical malpractice case against a local dermatologist who prescribed the acne medicine Accutane. Godfrey native Jason Peipert sued Dr. Daniel Goran of Edwardsville, Hoffman LaRoche Inc., and Roche Laboratories in 2003, claiming he developed Crohn's Disease, an inflammatory bowel disorder, after using the drug Goran prescribed 10 years ago. More>>>

What Is Ulcerative Colitis? What Causes Ulcerative Colitis?
-Medical News Today
09/13/2009 - Ulcerative colitis is a fairly common chronic (long-term) disease that causes inflammation of the colon (the large intestine). It is a form of inflammatory bowel disease that has some similarity to Crohn's disease, a related disorder. More>>>

Accutane trial set to begin in Madison County
-The Madison St.Clair Record
08/13/2009 - Madison County Circuit Judge Dave Hylla is set to preside over a medical malpractice trial Monday involving acne medication Accutane. Godfrey native Jason Peipert sued Dr. Daniel Goran, Hoffman LaRoche Inc., and Roche Laboratories in 2003, claiming he developed Crohn's Disease, an inflammatory bowel disorder, after using the drug Goran prescribed 10 years ago. More>>>

Acne Drug Accutane No Longer Sold
Generic Versions Still Available as Isotretinoin
-WebMD
07/09/2009 - Accutane won't be sold any more, drug giant Hoffmann-La Roche Inc. has announced. Generic versions of the acne drug, called isotretinoin, are still available from several manufacturers. But Roche, which has sold the drug to 13 million patients since 1982, will not be one of them. More>>>

The legal effects of withdrawal
-Irishtimes
07/07/2009 - The withdrawal of Roaccutane, the anti-acne drug, in the US has a huge effect on legal cases against its manufacturer here. The withdrawal last week of the anti-acne drug, Roaccutane, from the US market has “relevance” for up to 10 pending cases here against the drug manufacturer, Roche Pharmaceuticals, according to the main solicitor taking the cases. More>>>

Accutane off shelves, but lawsuits live
-THE COLUMBUS DISPATCH
07/06/2009 - Since 1982, Accutane has been a godsend and a curse. Millions of people who have used the prescription acne medication call it a miracle. But the drug also has been the target of lawsuits, federal investigations and scientists who say the drug is overused and that its dangers outweigh its benefits. More>>>

Accutane Finally Removed From the Market Proving Again That Lawsuits Are the Last Line of Defense Against Unsafe Drugs
-ThePopTort
07/03/2009 - Over the weekend Roche Holding, the maker of the dangerous acne drug Accutane took it off the shelves. This is a development that consumer groups have been calling for for years (as noted in Center for Justice & Democracy’s report, The Bitterest Pill, How Drug Companies Fail to Protect Women and How Lawsuits Save Their Lives.) More>>>

Drug At Center Of Local Trial Pulled From Market
-KDKA News
06/29/2009 - The drug maker, Roche, has pulled the acne drug Accutane off the market because of jury verdicts regarding bowel disease. The news comes as the drug's purported psychological effects are at the center of a defense argument in a local trial. More>>>

Roche Pulls Accutane Off Market After Jury Verdicts
-Bloomberg
06/27/2009 - Roche Holding AG, the world’s biggest maker of cancer drugs, is pulling its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. More>>>